Acute Limb Ischaemia: Recognition and Urgent Management

Definition and pathophysiology

Acute limb ischaemia (ALI) is an abrupt reduction in arterial perfusion of an upper or lower limb that causes tissue metabolic requirements to exceed available blood flow. The resulting ischaemia threatens skeletal muscle and peripheral nerves and may progress rapidly to irreversible tissue injury. Skeletal muscle and nerves generally tolerate ischaemia for approximately 4–6 hours, making ALI a medical emergency in which prompt recognition, specialist assessment and restoration of perfusion are essential.

The abrupt arterial obstruction may result from progression of peripheral arterial disease, cardiac or aortic embolisation, acute aortic dissection, thrombosis of a graft or aneurysm, popliteal artery entrapment, trauma, phlegmasia cerulea dolens, ergotism, hypercoagulable states or iatrogenic vascular injury. Acute occlusion may also occur in an artery with established collateral circulation, particularly an occluded bypass graft; in such cases, clinical manifestations may be less dramatic despite a sudden deterioration in function.

The severity of tissue injury depends on the site, duration and completeness of occlusion and on the adequacy of collateral blood flow. Ischaemia initially produces pain and sensory disturbance. With progression, motor dysfunction develops, followed by profound anaesthesia, paralysis, muscle rigidity and ultimately major tissue loss. Reperfusion after severe or prolonged ischaemia may be accompanied by rhabdomyolysis, with potential renal failure and increased mortality.

Clinical presentation and symptoms

Symptoms commonly develop rapidly, often within an hour of arterial occlusion. The classic clinical constellation is remembered as the “six Ps”:

• Pain

• Paresthesia

• Pallor

• Pulselessness

• Poikilothermia, or coldness

• Paralysis

Pain is often severe and is located distal to the arterial obstruction. Paresthesia, numbness and loss of sensation reflect peripheral nerve ischaemia. Motor dysfunction ranges from weakness to paralysis and is a particularly important marker of threatened limb viability. Paralysis generally indicates severe and persistent ischaemia.

The limb may be cold, pale, cyanotic or mottled. Capillary refill is delayed, and venous filling may be reduced. Other possible findings include muscle stiffening and loss of deep tendon reflexes. Pulses are absent distal to the obstruction, although Doppler examination may detect residual arterial flow in less advanced disease.

Clinical manifestations may be relatively modest when collateral circulation is adequate. For example, a patient with acute graft occlusion may report an abrupt reduction in walking distance before claudication, accompanied by moderate pain or paresthesia, while sensory and motor function remain preserved.

The duration and progression of symptoms should be documented carefully. Longer-standing and more severe pain or functional loss reduce the likelihood of successful limb salvage.

Evaluation and physical examination

ALI requires immediate clinical assessment by a vascular specialist or urgent transfer to a facility with vascular expertise. The initial evaluation should establish:

• The time of symptom onset and the rate of progression

• The location and severity of pain

• The presence and extent of sensory loss

• Any motor deficit or paralysis

• Skin colour and temperature

• Capillary refill and venous filling

• Pulses proximal and distal to the suspected obstruction

• Arterial and venous Doppler signals

• Evidence of systemic disease or a potential embolic source

Neurological assessment is central to triage. Sensory loss extending beyond the toes and, especially, any motor deficit indicate threatened viability and mandate emergency imaging and revascularisation. Severe sensory loss, profound anaesthesia and paralysis suggest that the limb may already be unsalvageable.

Clinical categories

ALI is classified according to neurological findings, Doppler signals and the likelihood of limb salvage.

Doppler findings can be especially useful when the neurological examination is difficult. Loss of the arterial signal supports threatened limb viability. A detectable arterial signal suggests that the limb may not be immediately threatened and may allow additional haemodynamic assessment. Absence of both arterial and venous signals, particularly when accompanied by extensive motor deficit, indicates probable irreversible injury.

Diagnostics

Duplex ultrasound

Duplex ultrasound (DUS) provides bedside assessment of arterial and venous flow and can help identify the level and haemodynamic significance of occlusion. In ALI, it is particularly useful when sensory or motor assessment is difficult. Its findings also assist in determining the urgency of intervention.

Computed tomography angiography

Computed tomography angiography (CTA) can demonstrate the location and extent of arterial occlusion and assist with procedural planning. The choice of imaging depends on local expertise, availability and the patient’s clinical status.

Magnetic resonance angiography

Contrast-enhanced magnetic resonance angiography (CE-MRA) is another option for defining the arterial obstruction. As with CTA and DUS, its use is determined by local resources and the need to avoid delays in reperfusion.

Digital subtraction angiography

Digital subtraction angiography (DSA) provides catheter-based vascular imaging and may be used to define the occlusion and facilitate endovascular treatment. In a severely threatened limb, imaging should not cause inappropriate delay to revascularisation.

Functional and haemodynamic assessment

The ankle–brachial index may be measured when arterial signals are present and the limb is not immediately threatened. In an acutely threatened limb, however, the clinical examination and Doppler findings take priority because urgent revascularisation is required.

Biomarkers and laboratory findings

Creatine kinase and myoglobin may be elevated as markers of skeletal-muscle injury. Markedly increased concentrations suggest rhabdomyolysis and are associated with increased risks of amputation, kidney failure and mortality. In chronic or gradually evolving ischaemia, these biomarkers may be less elevated, potentially reflecting ischaemic preconditioning and collateral development.

The source material does not specify a complete laboratory protocol for ALI. Laboratory assessment should therefore be integrated with the clinical examination and vascular imaging rather than used to exclude the diagnosis.

Treatment and management

Immediate priorities

ALI should be managed as a time-critical emergency:

• Recognise the syndrome clinically.

• Assess symptom duration and limb viability.

• Obtain urgent vascular specialist input.

• Begin anticoagulation with intravenous heparin once the diagnosis is established, to limit thrombus propagation and recurrent embolisation.

• Arrange urgent imaging when required for treatment planning.

• Proceed rapidly to revascularisation when the limb is threatened.

The urgency is greatest in category IIb disease, where motor dysfunction indicates immediate threat. Category III disease is characterised by profound neurological injury, absent arterial and venous Doppler signals and absent capillary refill; in this setting, amputation is required because tissue loss and permanent nerve damage are inevitable.

Revascularisation strategies

The choice of intervention depends on the cause, anatomical site, duration and severity of ischaemia, the patient’s overall condition and the availability of expertise.

Catheter-directed thrombolysis

Intra-arterial thrombolysis using recombinant tissue plasminogen activator, reteplase or tenecteplase is most effective when the occlusion is recent and thrombotic, particularly in an atherosclerotic artery, bypass graft or occluded stent. It may also be selected when surgical intervention is contraindicated or when distal-vessel occlusion prevents surgical access.

Treatment requires meticulous surveillance for haemorrhagic complications. Ultrasound-emitting catheters may enhance thrombus permeability and accelerate drug-mediated reperfusion.

Percutaneous mechanical thrombectomy

Mechanical thrombectomy devices can fragment and remove thrombus using hydrodynamic forces or rotating baskets. These techniques may be used alone, but are commonly combined with pharmacological thrombolysis.

Surgical revascularisation

Surgical thromboembolectomy or arterial bypass may be required, particularly when a large proximal vessel is occluded or when blood flow must be restored within 24 hours to prevent limb loss. Surgical treatment is also relevant when endovascular treatment is not feasible or has failed.

Amputation

Amputation is indicated when the limb is non-viable. The combination of loss of sensation, paralysis and absent Doppler flow in both arteries and veins is characteristic of irreversible injury.

Treatment according to clinical category

Management of the underlying cause

ALI is frequently thromboembolic, and the source of embolisation should be investigated after initial limb management. Cardiac and aortic causes are particularly important. Emboli associated with infective endocarditis, prosthetic heart valves or atrial myxoma may require surgical treatment directed at the source.

Long-term anticoagulation is indicated when ALI results from cardiac thromboembolism. The specific agent and regimen are not stated in the source material.

Guideline recommendations

The guideline-based principles for ALI are:

• ALI requires rapid clinical evaluation by a vascular team.

• Neurological deficits, particularly motor impairment, signify threatened limb viability and require emergency imaging and revascularisation.

• Loss of both arterial and venous Doppler signals with extensive motor deficit suggests an irreversible limb.

• Intravenous heparin should be started after diagnosis to prevent thrombus extension and recurrent embolisation.

• Catheter-directed thrombolysis, mechanical thrombectomy, surgical thromboembolectomy and bypass are available revascularisation approaches.

• Surgical revascularisation is preferred when restoration of flow is required within 24 hours to prevent limb loss.

• Following revascularisation or amputation, haemodynamic success should be confirmed, the cause of ALI investigated and optimal medical treatment ensured.

• Holter electrocardiography, echocardiography and aortic imaging are useful in identifying thromboembolic sources and guiding anticoagulation.

• Antiphospholipid syndromes and vasculitis should be considered when clinically suspected.

Prognosis

Prognosis is determined primarily by the initial degree of neurological impairment, the duration and severity of ischaemia, the presence of arterial and venous Doppler signals and the adequacy of collateral circulation.

A viable limb has no immediate threat. A marginally threatened limb is generally salvageable with prompt treatment, whereas an immediately threatened limb requires immediate revascularisation. Profound anaesthesia, paralysis, absent arterial and venous Doppler signals and absent capillary refill indicate irreversible injury, with inevitable major tissue loss and permanent nerve damage.

Prolonged or severe ischaemia increases the risk of muscle necrosis and rhabdomyolysis. Markedly elevated creatine kinase or myoglobin identifies patients at increased risk of amputation, kidney failure and mortality.

Follow-up after revascularisation or amputation

Follow-up should establish that perfusion has been restored and should address both the precipitating mechanism and long-term vascular risk. Key elements include:

• Confirmation of haemodynamic success

• Investigation for cardiac, aortic and other embolic sources

• Holter electrocardiography when thromboembolism is suspected

• Echocardiography and aortic imaging

• Assessment for antiphospholipid syndromes or vasculitis when clinically indicated

• Institution of appropriate long-term anticoagulation for cardiac thromboembolic ALI

• Optimal medical treatment, including statin therapy

• Monitoring of limb symptoms, functional status, pulses and foot condition

• Coordination among clinicians involved in vascular and comorbidity management

Structured follow-up after revascularisation may improve functional outcomes, although the evidence described is limited. Longitudinal assessment should include periodic review of symptoms and walking or functional capacity, physical examination of the lower extremity and foot, quality of life and progress in risk-factor management. When new lower-limb signs or symptoms develop after revascularisation, ankle–brachial index measurement and arterial duplex ultrasound are recommended.